Literature DB >> 12384925

Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus.

G P Th Bosma1, H A M Middelkoop, M J Rood, E L E M Bollen, T W J Huizinga, M A van Buchem.   

Abstract

OBJECTIVE: To investigate the relationship between quantitative estimates of global brain damage based on magnetization transfer imaging (MTI) and cerebral functioning, as measured by neurologic, psychiatric, and cognitive assessments, as well as disease duration in patients with a history of neuropsychiatric systemic lupus erythematosus (NPSLE).
METHODS: In a clinically heterogeneous group of 24 female patients (age range 19-65 years, mean age 35 years) with a history of NPSLE, the correlation values of several volumetric MTI measures and an estimate of cerebral atrophy, neurologic functioning (Kurtzke's Expanded Disability Status Scale [EDSS]), psychiatric functioning (the Hospital Anxiety and Depression Scale [HADS]), and cognitive functioning (cognitive impairment score [CIS] derived from the revised Wechsler Adult Intelligence Scale), as well as several measures of disease duration were assessed using Pearson's correlation coefficient.
RESULTS: Quantitative volumetric estimates of global brain damage based on MTI and a measure of global brain atrophy correlated significantly with the EDSS, HADS, and CIS scores. No significant correlation was found between the quantitative estimates of global brain damage and the measures of disease duration.
CONCLUSION: The results of this study demonstrate that volumetric MTI parameters and cerebral atrophy reflect functionally relevant brain damage in patients with NPSLE. Furthermore, the absence of a linear relationship between disease duration and results of volumetric MTI measures and atrophy suggests a complicated pattern of accumulating brain damage in patients with NPSLE.

Entities:  

Mesh:

Year:  2002        PMID: 12384925     DOI: 10.1002/art.10574

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  17 in total

1.  Neuroimaging evidence of white matter inflammation in newly diagnosed systemic lupus erythematosus.

Authors:  Amy E Ramage; Peter T Fox; Robin L Brey; Shalini Narayana; Matthew D Cykowski; Mohammad Naqibuddin; Margaret Sampedro; Stephen L Holliday; Crystal Franklin; Daniel J Wallace; Michael H Weisman; Michelle Petri
Journal:  Arthritis Rheum       Date:  2011-10

2.  Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institution.

Authors:  E Muscal; D R Bloom; J V Hunter; B L Myones
Journal:  Lupus       Date:  2009-12-21       Impact factor: 2.911

3.  Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice.

Authors:  Michelle M Sidor; Boris Sakic; Paul M Malinowski; David A Ballok; Curtis J Oleschuk; Joseph Macri
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

4.  Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation.

Authors:  Essam A Abda; Zahraa I Selim; Moustafa E M Radwan; Nagham M Mahmoud; Omar M Herdan; Khalid A Mohamad; Sherifa A Hamed
Journal:  Rheumatol Int       Date:  2012-10-12       Impact factor: 2.631

5.  Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus.

Authors:  Rex E Jung; Judith M Segall; Rachael G Grazioplene; Clifford Qualls; Wilmer L Sibbitt; Carlos A Roldan
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

Review 6.  Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve.

Authors:  Massimo Filippi; Maria A Rocca
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 7.  Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis.

Authors:  R H B Benedict; J L Shucard; R Zivadinov; D W Shucard
Journal:  Neuropsychol Rev       Date:  2008-06-03       Impact factor: 7.444

Review 8.  Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.

Authors:  Tony N Marion; Arnold E Postlethwaite
Journal:  Semin Immunopathol       Date:  2014-08-08       Impact factor: 9.623

9.  Disturbed distribution of proliferative brain cells during lupus-like disease.

Authors:  Mile Stanojcic; Tal Burstyn-Cohen; Nadia Nashi; Greg Lemke; Boris Sakic
Journal:  Brain Behav Immun       Date:  2009-06-06       Impact factor: 7.217

Review 10.  New insights into central nervous system lupus: a clinical perspective.

Authors:  John G Hanly
Journal:  Curr Rheumatol Rep       Date:  2007-05       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.